肾病/中医药疗法
肾病/中医药疗法的相关文献在1997年到2016年内共计89篇,主要集中在中国医学、内科学、外科学
等领域,其中期刊论文89篇、专利文献38972篇;相关期刊11种,包括吉林中医药、内蒙古中医药、陕西中医等;
肾病/中医药疗法的相关文献由219位作者贡献,包括杨明丽、呼兴华、程小红等。
肾病/中医药疗法—发文量
专利文献>
论文:38972篇
占比:99.77%
总计:39061篇
肾病/中医药疗法
-研究学者
- 杨明丽
- 呼兴华
- 程小红
- 胡筱娟
- 路波
- 史健
- 孙元莹
- 张琪
- 张福华
- 曹式丽
- 李秋英
- 李群
- 樊平
- 沈璐
- 肖洋
- 胡宝峰
- 胡海兵
- 郭茂松
- 马浩
- 黄勇
- 万强
- 于卓
- 于小勇
- 于文亚
- 任小强
- 任灵红
- 伍德明
- 何晶
- 何立群
- 何紫阳
- 余晖
- 侯爱萍
- 倪佳
- 倪其猛
- 党兰玉
- 冉颖卓
- 刘孟珍
- 刘宏斌
- 刘宝利
- 刘平
- 刘建红
- 刘志伟
- 刘晓春
- 刘洪波
- 刘爱霞
- 刘玉玲
- 刘瑞云
- 刘香春
- 卫德强
- 史伟
-
-
王三合;
康晓玲;
樊平;
陈群
-
-
摘要:
目的:观察益肾方对Ig A肾病模型大鼠细胞因子表达的影响。方法:将40只SD大鼠随机分为正常对照组10只,造模组30只两组,采用口服牛血清白蛋白联合尾静脉注射葡萄球菌肠毒素B法造模。将Ig A肾病模型大鼠分成3组:益肾方组、造模组、强的松治疗组各10只。分别灌胃给药,4周后取血,酶联免疫法(ELISA )测定IL‐6、Leptin和PDGF水平。结果:与模型组比较,各药物治疗组均有IL‐6、Leptin和PDGF表达降低作用;与正常对照组比较,各组IL‐6、Leptin和PDGF表达均增强(P<0.05);与模型组比较,益肾方能显著降低IL‐6、Leptin和PDGF的表达。结论:益肾方可能是通过降低IL‐6、Leptin和PDGF的表达治疗Ig A肾病。%Objective:To observe the effects of cytokine expression of Yishen‐Fang treatment in IgAN rats . Methods :40 SD rats were randomly divided into two groups ,10 for normal control group ,30 for model group .30 IgAN rats were randomly divided into 3 groups :Yishen‐Fang treatment group ,model group ,prednisone treatment group . There are 10 rats in each group .After Gavage for four weeks ,the blood was collected .The IL‐6 ,Leptin and PDGF val‐ues were measured by enzyme‐linked immunosorbent assay (ELISA) .Results :Compared with the model group ,the ex‐pression of IL‐6 ,Leptin and PDGF values decrease were shown in all drug treatment groups .Compared with the normal control group ,the values of IL‐6 ,Leptin and PDGF in each group were significantly increased(P<0 .05) .The expression of IL‐6 ,Leptin and PDGF in the Yishen‐Fang treatment group was significantly reduced when compared with the model group .Conclusion:Yishen‐Fang may treat the IgAN rats by reducing the expression of IL‐6 ,Leptin and PDGF .
-
-
-
何紫阳;
蓝家荣
-
-
摘要:
通过对相关临床文献的搜集、整理及归纳,本文从糖尿病肾病(DN)的发病机制、大黄的相关药理作用及大黄治疗糖尿病肾病(DN)的研究与应用3个方面进行分析、研究.结果表明:大黄能有效减少肠道中氨基氮的重吸收,改善氮质血症,抑制残余肾组织的代偿性肥大,抑制肾小球系膜细胞的增殖、纠正脂代谢紊乱,减少蛋白尿,改善微循环、抗凝、抗血栓等降低微血管并发症的相关作用.由此可见,中药大黄及其提取物对DN有较好的疗效,并取得了可喜的成绩.现笔者就相关文献作一综述.
-
-
-
李雯雯;
吴卿;
沈沛成;
何立群
-
-
摘要:
目的:观察益气固本调免方调和营卫治疗Ig A 肾病的临床疗效。方法:将85例Ig A 肾病(CKD1‐4期)随机分为两组;治疗组43例给予益气固本调免方治疗,对照组42例给予科素亚治疗,疗程4个月。结果:总有效率治疗组为74.4%,对照组为42.9%,组间疗效比较有统计学差异。治疗组尿红细胞计数和24h尿蛋白定量显著降低,IgA 及补体C3有显著改善,CD4显著升高,CD8显著降低,CD4/CD8比值显著上升。对照组24h尿蛋白定量降低, Ig A有降低趋势、补体C3有升高趋势,但无统计学差异,CD4、CD8、CD4/CD8比值无明显改善;两组各指标组间比较有显著统计学差异。结论:益气固本调免方调和营卫有效减少Ig A肾病患者的血尿和蛋白尿,其机制与调节体液免疫和细胞免疫功能有关。%Objective:The aim of this study was to investigate the effect of Yiqi Guben Tiaomian formula in IgA nephropathy patients in chronic kidney disease (CKD) stage 1‐4 .Methods:In this randomized controlled clinical study ,85 patients were enrolled .They were randomized into treatment group (43 cases ,Yiqi Guben Tiaomian formula) and control group (42 cases ,losartan) ,with a four‐month course of therapies .Results:The total effective rate was 74 .4% in treat‐ment group and 42 .9% in control group ,with a significant difference between the two rates .Only 24h urinary protein ex‐cretion were reduced in control group ,whereas red blood cell count of urine and 24h urinary protein excretion were obvi‐ously reduced in treatment group ,with significant differences between the two groups .When compared the results of con‐trol group ,IgA ,C3 ,CD4 ,CD8 ,and CD4/CD8 were significantly improved in the treatment group .Conclusion:Yiqi Guben Tiaomian formula is effective to improve hematuria and proteinuria in IgA nephropathy patients ,due to regulate humoral and cellular immunity .
-
-
-
-
-